Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent
Christopher R. AndersonXiaowen HuHua ZhangJosé L. TlaxcaAnne‐Émilie DeclèvesRobert HoughtalingKumar SharmaRobert LawrenceKatherine W. FerraraJoshua J. Rychak
Abstract
The results demonstrate the functionality of a novel MB contrast agent covalently coupled to an RGD peptide for ultrasound molecular imaging of αvβ3 integrin and the feasibility of quantitative molecular ultrasound imaging with a low MI.
Metrics
Citation History
Topics
Related Documents
A Lipopeptide-Based αvβ3 Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis
Fei YanXiu-xia XuYihan ChenZhiting DengHongmei LiuJian-Rong XuJie ZhouGuang‐Hong TanJunru WuHairong Zheng
VEGFR‐2 Targeted Microbubble Contrast Agents for Ultrasound Molecular Imaging of Tumor Angiogenesis
Christopher R. AndersonJoshua J. RychakJoseph M. BackerKlaus LeyAlexander L. Klibanov
Development of an angiogenesis-targeted microbubble ultrasound contrast agent
Howard Leong‐PoiAlexander L. KlibanovJ. ChristiansenYuqing HuoJonathan R. Lindner
Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble
Hua ZhangSarah TamElizabeth S. InghamLisa M. MahakianChun‐Yen LaiSpencer K. TumbaleTambet TeesaluNeil E. HubbardAlexander D. BorowskyKatherine W. Ferrara
Novel Targeted Contrast Agent for Ultrasound Molecular Imaging of αvβ3 Integrin
Christopher R. AndersonJoshua J. RychakXiaowen HuKatherine W. Ferrara